BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10555547)

  • 21. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
    Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
    Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of the VPAC2 receptor in peripheral tissues of the mouse.
    Harmar AJ; Sheward WJ; Morrison CF; Waser B; Gugger M; Reubi JC
    Endocrinology; 2004 Mar; 145(3):1203-10. PubMed ID: 14617572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist.
    Moody TW; Jensen RT; Fridkin M; Gozes I
    J Mol Neurosci; 2002; 18(1-2):29-35. PubMed ID: 11931347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos.
    Gressens P; Hill JM; Gozes I; Fridkin M; Brenneman DE
    Nature; 1993 Mar; 362(6416):155-8. PubMed ID: 8383805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss).
    Montpetit CJ; Shahsavarani A; Perry SF
    J Exp Biol; 2003 Jun; 206(Pt 11):1917-27. PubMed ID: 12728013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Affection of epidermal growth factor on VIP secretion and VIPR expression in airway epithelial cells].
    Qin X; Sun X; Luo Z; Guan C; Zhang C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):99-102. PubMed ID: 11938800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16.
    Langer I; Perret J; Vertongen P; Waelbroeck M; Robberecht P
    Cell Calcium; 2001 Oct; 30(4):229-34. PubMed ID: 11587546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
    Elgavish A; Pillion DJ; Meezan E
    Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal peptide influences hatching of ovine blastocysts.
    Leoni G; Bogliolo L; Deledda F; Ledda S; Naitana S
    Reprod Fertil Dev; 2000; 12(1-2):7-14. PubMed ID: 11194560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of vasoactive intestinal peptide (VIP) and its binding sites in labial salivary glands in Sjögren's syndrome and in normal controls.
    Törnwall J; Uusitalo H; Hukkanen M; Sorsa T; Konttinen YT
    Clin Exp Rheumatol; 1994; 12(3):287-92. PubMed ID: 8070162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Castration-resistant secretion in the hamster seminal vesicle does not depend on androgens.
    Pinho MS; Mata LR
    Int J Androl; 1992 Oct; 15(5):435-47. PubMed ID: 1428201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of vasoactive intestinal polypeptide binding sites in guinea pig genital tissues.
    Inyama CO; Wharton J; Davis CJ; Jackson RH; Bloom SR; Polak JM
    Neurosci Lett; 1987 Oct; 81(1-2):111-6. PubMed ID: 2827063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.
    Haegerstrand A; Jonzon B; Dalsgaard CJ; Nilsson J
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5993-6. PubMed ID: 2474824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.